MGP Ingredients financials
$13.34+4.38%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $124.4M | $106.4M | $138.3M | $130.9M | $145.5M | $121.7M | $180.8M | $161.5M | $190.8M | $170.6M | $214.9M | $211.6M |
| Gross profit | $46.5M | $33.6M | $48.3M | $49.4M | $58.4M | $43.3M | $74.5M | $65.8M | $83.2M | $62.8M | $85.1M | $73.4M |
| Gross margin | 37.4% | 31.6% | 34.9% | 37.8% | 40.1% | 35.6% | 41.2% | 40.8% | 43.6% | 36.8% | 39.6% | 34.7% |
| Operating income | $17.7M | -$173.2M | -$135.2M | $21.0M | $20.3M | -$747.0K | -$30.4M | $32.6M | $43.4M | $28.9M | $43.1M | $19.8M |
| Net income | $11.9M | -$134.8M | -$133.0M | $15.2M | $14.3M | -$3.0M | -$41.5M | $23.6M | $32.1M | $20.4M | $30.8M | $13.1M |
| Net margin | 9.5% | −126.7% | −96.2% | 11.6% | 9.8% | −2.5% | −23.0% | 14.6% | 16.8% | 12.0% | 14.3% | 6.2% |
| Diluted EPS | $0.55 | $-6.30 | $-6.22 | $0.71 | $0.67 | $-0.14 | $-1.91 | $1.07 | $1.43 | $0.92 | $1.39 | $0.58 |
| EBITDA | $24.8M | $12.6M | $23.7M | $27.2M | $26.1M | $5.1M | $49.0M | $38.2M | $48.7M | $38.4M | $52.9M | $48.2M |
| Operating cash flow | -$49.2M | $8.5M | $29.1M | $36.1M | $11.7M | $44.7M | $28.8M | $43.9M | $5.0M | $24.6M | $35.2M | $28.4M |
| Free cash flow | -$53.7M | $2.7M | $24.3M | $27.6M | -$557.0K | $24.8M | $10.4M | $24.5M | -$1.4M | -$2.4M | $22.0M | $16.4M |
| Diluted shares | 21.4M | 21.4M | 21.4M | 21.4M | 21.4M | 21.3M | 21.7M | 22.1M | 22.1M | 22.1M | 22.1M | 22.4M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $17.8M | $10.4M | $18.5M | $13.4M | $17.3M | $20.1M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $369.6M | $245.0M | $252.3M | $268.7M | $297.1M | $297.1M |
| Total assets | $1.06B | $1.03B | $1.24B | $1.38B | $1.39B | $1.38B |
| Total liabilities | $466.9M | $451.7M | $519.1M | $523.5M | $545.9M | $551.5M |
| Shareholders' equity | $590.8M | $579.6M | $716.8M | $853.5M | $840.1M | $826.7M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology